• Je něco špatně v tomto záznamu ?

Synchronous second primary neoplasms detected by initial staging F-18 FDG PET/CT examination in patients with non-Hodgkin lymphoma

T. Papajík, M. Mysliveček, Z. Sedová, E. Buriánková, V. Procházka, L. Raida, Z. Kubová, C. Neoral, D. Starostka, P. Mikula, B. Melichar, L. Kučerová, M. Tichý, K. Indrák,

. 2011 ; 36 (7) : 509-12.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12027508

Grantová podpora
NR9502 MZ0 CEP - Centrální evidence projektů

PURPOSE OF THE REPORT: Cases of synchronous non-Hodgkin lymphoma (NHL) and second primary carcinoma in previously untreated immunocompetent patients are relatively rare. The aim of this part of our prospective study was to a revealed 2-F-18 fluoro-2-deoxy-D-glucose (F-18 FDG) positron emission tomography (PET)-positive lesion in an extranodal organ suggestive of second primary neoplasm in newly diagnosed NHL patients. MATERIALS AND METHODS: A total of 209 patients with NHL underwent initial staging F-18 FDG PET/computed tomography (CT). The finding was assessed by a radiologist, nuclear medicine physician, and hematologist. In 6 suspicious cases (2.9%) of second neoplasm, the decision was made to perform further investigations before lymphoma therapy. RESULTS: Two patients were diagnosed with colorectal carcinoma, 1 with esophageal adenocarcinoma, 1 with invasive ductal breast carcinoma, 1 with medullary thyroid carcinoma, and 1 with squamous cell lung carcinoma. In 5 of the 6 patients, the second solid tumor was completely asymptomatic and revealed only by F-18 FDG PET/CT examination. CONCLUSIONS: We conclude that in patients with NHL, appropriate imaging, clinical, and histologic analysis of organ lesions detected by F-18 FDG PET/CT will occasionally demonstrate significant synchronous neoplasms.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12027508
003      
CZ-PrNML
005      
20170615134129.0
007      
ta
008      
120817s2011 xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1097/rlu.0b013e318217541d $2 doi
035    __
$a (PubMed)21637049
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Papajík, Tomáš, $u Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic. tomas.papajik@fnol.cz $d 1967- $7 xx0060566
245    10
$a Synchronous second primary neoplasms detected by initial staging F-18 FDG PET/CT examination in patients with non-Hodgkin lymphoma / $c T. Papajík, M. Mysliveček, Z. Sedová, E. Buriánková, V. Procházka, L. Raida, Z. Kubová, C. Neoral, D. Starostka, P. Mikula, B. Melichar, L. Kučerová, M. Tichý, K. Indrák,
520    9_
$a PURPOSE OF THE REPORT: Cases of synchronous non-Hodgkin lymphoma (NHL) and second primary carcinoma in previously untreated immunocompetent patients are relatively rare. The aim of this part of our prospective study was to a revealed 2-F-18 fluoro-2-deoxy-D-glucose (F-18 FDG) positron emission tomography (PET)-positive lesion in an extranodal organ suggestive of second primary neoplasm in newly diagnosed NHL patients. MATERIALS AND METHODS: A total of 209 patients with NHL underwent initial staging F-18 FDG PET/computed tomography (CT). The finding was assessed by a radiologist, nuclear medicine physician, and hematologist. In 6 suspicious cases (2.9%) of second neoplasm, the decision was made to perform further investigations before lymphoma therapy. RESULTS: Two patients were diagnosed with colorectal carcinoma, 1 with esophageal adenocarcinoma, 1 with invasive ductal breast carcinoma, 1 with medullary thyroid carcinoma, and 1 with squamous cell lung carcinoma. In 5 of the 6 patients, the second solid tumor was completely asymptomatic and revealed only by F-18 FDG PET/CT examination. CONCLUSIONS: We conclude that in patients with NHL, appropriate imaging, clinical, and histologic analysis of organ lesions detected by F-18 FDG PET/CT will occasionally demonstrate significant synchronous neoplasms.
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fluorodeoxyglukosa F18 $x diagnostické užití $7 D019788
650    _2
$a lidé $7 D006801
650    _2
$a nehodgkinský lymfom $x patologie $x radiografie $x radioizotopová diagnostika $7 D008228
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a staging nádorů $7 D009367
650    _2
$a sekundární malignity $x radiografie $x radioizotopová diagnostika $7 D016609
650    _2
$a pozitronová emisní tomografie $7 D049268
650    _2
$a počítačová rentgenová tomografie $7 D014057
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mysliveček, Miroslav
700    1_
$a Sedová, Zuzana
700    1_
$a Buriánková, Eva
700    1_
$a Procházka, Vít $7 xx0143822
700    1_
$a Raida, Luděk
700    1_
$a Kubová, Zuzana
700    1_
$a Neoral, Cestmír
700    1_
$a Starostka, David
700    1_
$a Mikula, Petr
700    1_
$a Melichar, Bohuslav
700    1_
$a Kučerová, Ladislava
700    1_
$a Tichý, Martin
700    1_
$a Indrák, Karel
773    0_
$w MED00001147 $t Clinical nuclear medicine $x 1536-0229 $g Roč. 36, č. 7 (2011), s. 509-12
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21637049 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120817 $b ABA008
991    __
$a 20170615134543 $b ABA008
999    __
$a ok $b bmc $g 949550 $s 784854
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 36 $c 7 $d 509-12 $i 1536-0229 $m Clinical nuclear medicine $n Clin Nucl Med $x MED00001147
GRA    __
$a NR9502 $p MZ0
LZP    __
$a Pubmed-20120817/11/03

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace